Estrogen for schizophrenia

  • Chua W
  • Izquierdo de Santiago A
  • Kulkarni J
  • et al.
67Citations
Citations of this article
180Readers
Mendeley users who have this article in their library.
Get full text

Abstract

BACKGROUND: In terms of clinical outcomes, women with schizophrenia seem to fare better then men, but appear more vulnerable to psychotic illness in the period after birth and menopause. As these vulnerable periods to psychosis are associated with estrogen withdrawal, this hormone has been proposed as a treatment for schizophrenia. OBJECTIVES: To evaluate the clinical effects of estrogens alone or in combination with progesterone,

Cite

CITATION STYLE

APA

Chua, W. L. L., Izquierdo de Santiago, A., Kulkarni, J., & Mortimer, A. (2005). Estrogen for schizophrenia. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd004719.pub2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free